AbataCept for the Treatment of Immune-cHeckpoint Inhibitors Induced mYocarditiS
Condition:   Myocarditis Intervention:   Drug: Abatacept 250 MG Sponsor:   Assistance Publique - Hôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2022 Category: Research Source Type: clinical trials

Expanded Access for Abatacept
Condition:   Intervention:   Biological: Abatacept Sponsor:   Bristol-Myers Squibb Available (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 28, 2021 Category: Research Source Type: clinical trials